8-KMaterial AgreementsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Material Agreement (Sep 19, 2016)

Filed September 19, 2016For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) announced the issuance of $1.2 billion in aggregate principal amount of 2.950% Senior Notes due 2026 through a public offering. The company intends to use a significant portion of the net proceeds, approximately $1.18 billion after expenses, to redeem its outstanding $900 million of 1.30% senior notes due 2017. The remaining proceeds will be used for general corporate purposes. This debt issuance and the subsequent redemption of the 2017 notes represent a strategic financial move by Thermo Fisher. By replacing short-term, higher-interest debt with longer-term, lower-interest debt, the company aims to improve its interest expense profile and extend its debt maturity. Investors should note the details of the new notes, including their maturity, interest rate, and redemption provisions, as well as the covenant limitations outlined in the indenture.

Key Highlights

  • 1Issued $1.2 billion in 2.950% Senior Notes due 2026.
  • 2Intends to use approximately $1.18 billion in net proceeds to redeem $900 million of 1.30% senior notes due 2017.
  • 3The remaining proceeds are designated for general corporate purposes.
  • 4The new notes mature on September 19, 2026, with semi-annual interest payments of 2.950% per annum.
  • 5The company has the option to redeem the notes prior to maturity under specific conditions and pricing.
  • 6The notes are general unsecured obligations and are effectively subordinated to secured debt and structurally subordinated to subsidiaries' debt.
  • 7The indenture includes covenants restricting secured debt, sale-leaseback transactions, and mergers/consolidations.

Frequently Asked Questions

The primary purpose is to refinance existing debt. Thermo Fisher intends to use a substantial portion of the net proceeds to redeem its $900 million of 1.30% senior notes due in 2017, effectively replacing short-term debt with longer-term debt at a lower interest rate.

The notes mature on September 19, 2026, carry a fixed interest rate of 2.950% per annum, payable semi-annually. The company has options to redeem the notes prior to maturity under certain conditions, and a change of control provision requires a repurchase offer if the notes are downgraded.

This transaction will extend the company's debt maturity profile and potentially reduce its overall interest expense. It demonstrates proactive debt management and a focus on optimizing the company's capital structure.

The notes are general unsecured obligations, meaning they rank equally with other unsecured debt but are subordinated to secured debt. They are also structurally subordinated to the debt of Thermo Fisher's subsidiaries. Investors should also consider the company's ability to meet covenant requirements and the potential for early redemption by the company.